Bladder Cancer WeeklySent on 22 June 2026
Bladder-Sparing Treatment Decisions in BCG-Unresponsive NMIBCSent on 18 June 2026
Bladder Cancer WeeklySent on 15 June 2026
High-Risk NMIBC: Bladder Preservation, BCG Challenges, and Evolving Treatment PathwaysSent on 13 June 2026
Experts Discuss Bladder Cancer Controversies: Rapid-Fire DebatesSent on 12 June 2026
Improving Bladder-Sparing Decisions in NMIBCSent on 09 June 2026
Bladder Cancer WeeklySent on 08 June 2026
Rethinking Treatment Pathways in Recurrent Low-Grade NMIBCSent on 04 June 2026
ASCO 2026 Advancing Curative Strategies in Bladder and Kidney CancerSent on 01 June 2026
Bladder Cancer WeeklySent on 01 June 2026
Novel Approaches to Curing Bladder and Kidney Cancer at ASCO 2026Sent on 30 May 2026
Emerging RCC and Bladder Cancer Data From ASCO Day 1Sent on 30 May 2026
Key GU Oncology Data to Watch at ASCO 2026Sent on 26 May 2026
Bladder Cancer WeeklySent on 25 May 2026
Making Bladder-Sparing Decisions in High-Risk NMIBCSent on 23 May 2026
AUA-IBCG Bladder Cancer Forum: Debating the Future of Bladder Cancer CareSent on 22 May 2026
Emerging Strategies in NMIBC from AUA 2026Sent on 19 May 2026
Bladder Cancer WeeklySent on 18 May 2026
AUA 2026 Advances in NMIBC Treatment and Risk StratificationSent on 17 May 2026
AUA 2026 Updates in MIBC and Advanced Urothelial CancerSent on 17 May 2026
AUA 2026 Updates in Kidney-Sparing and Bladder Cancer StrategiesSent on 16 May 2026
AUA 2026 Plenary Headlines: Durvalumab (POTOMAC) and Pembrolizumab Combined with BCG in High-Risk NMIBCSent on 16 May 2026
American Urological Association (AUA) 2026 Practice-Changing, Paradigm-Shifting Clinical Trials in Urology and NMIBC HighlightsSent on 15 May 2026
Key Bladder and Prostate Cancer Data to Watch at AUA 2026Sent on 13 May 2026
Rethinking Bladder-Sparing Strategies After BCG Exposure or FailureSent on 12 May 2026
Bladder Cancer WeeklySent on 11 May 2026
You’re Invited to a Bladder Cancer Patient Experience Discussion on May 14Sent on 09 May 2026
Bladder Cancer WeeklySent on 04 May 2026
Evolving Care for Low-Grade Intermediate-Risk NMIBCSent on 30 April 2026
Bladder Cancer WeeklySent on 27 April 2026
Bladder Cancer WeeklySent on 20 April 2026
Optimizing Care after BCG Failure in Bladder CancerSent on 14 April 2026
Bladder Cancer WeeklySent on 13 April 2026
NMIBC Treatments in Development Sent on 09 April 2026
Bladder Cancer WeeklySent on 06 April 2026
Managing Recurrence Without Overtreatment in NMIBCSent on 04 April 2026
Bladder Cancer Controversies: Rapid-Fire Debates from EAU26Sent on 01 April 2026
Bladder Cancer WeeklySent on 30 March 2026
Managing BCG-Unresponsive Bladder Cancer in Real PracticeSent on 25 March 2026
Bladder Cancer WeeklySent on 23 March 2026
Insights Across GU Oncology from Prostate, Bladder, and Kidney Cancer: SES AUA 2026Sent on 20 March 2026
Emerging and Practice Informing Data in Bladder Cancer from SES AUA 2026Sent on 19 March 2026
Data Shaping Care in Renal and Upper Tract Cancers from EAU 2026Sent on 16 March 2026
Bladder Cancer WeeklySent on 16 March 2026
EAU 2026 Where Bladder Cancer Treatment Is Heading NextSent on 15 March 2026
EAU 2026: Surgery and Intravesical Therapy in NMIBCSent on 14 March 2026
EAU 2026: Bladder Sparing Treatment in Non-Muscle Invasive Bladder CancerSent on 14 March 2026
Biomarkers for Guiding Bladder Cancer Treatment DecisionsSent on 10 March 2026
Bladder Cancer WeeklySent on 09 March 2026
Honoring Women Who Educate, Innovate, and Inspire in Urologic Care and ResearchSent on 08 March 2026
  • Page of 16
Display #
Results 1 - 50 out of 786